Health and Healthcare
5864 Articles
Gilead Sciences, Inc. (Nasdaq: GILD) has agreed to buy CV Therapeutics, Inc. (Nasdaq: CVTX) for $20.00 per share in cash.
Pfizer Inc. (NYSE: PFE) is stopping its Phase III clinical trial of Sutent early. This is generally a scare over…
Before Roche decided to try to buy the 44% of biotech company Genentech (DNA) that it did not already own…
Pfizer Inc. (NYSE: PFE) just got its long-term ratings downgraded by Moody’s. It is amazing that bond ratings agencies still…
The AMA, the federal government, and most insurance companies and HMOs have been arguing that storing and updating medical records…
Merck (MRK) is merging with Schering-Plough (SGP) in a deal that the companies say is worth $41.1 billion. In reality,…
Roche has apparently capitulated in its fight to take over Genentech Inc. (NYSE: DNA). Its cancer franchise and its pipeline,…
We are seeing unusual trading activity so far this morning in shares of Dendreon Corp. (NASDAQ: DNDN), Genentech, Inc. (NYSE:…
For years, Americans have assumed that the FDA was set up to test drugs. If a treatment was not effective…
How long has it been since a company announced a stock split? More importantly, when was the last from a…
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know…
Geron Corporation (NASDAQ: GERN) had a filing to sell shares that hit after teh close today. Normally this would be…
CV Therapeutics, Inc. (NASDAQ: CVTX) is seeing a surge in its shares this morning. It looks like CV is the…
Medidata Solutions, Inc. has filed with the SEC to come public via an initial public offering. The company has applied…
Thomas Alva Edison accumulated 1,093 US patents over his lifetime. Most R&D operations are not that efficient. Corporations hate research.…
Our top personal finance-related articles today. Your wallet will thank you later.